BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 30587005)

  • 1. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.
    Kartush AG; Schumacher JK; Shah R; Patadia MO
    Am J Rhinol Allergy; 2019 Mar; 33(2):203-211. PubMed ID: 30587005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
    Bachert C; Gevaert P; Hellings P
    J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A; Liang J
    Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.
    Codispoti CD; Mahdavinia M
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):232-239. PubMed ID: 31295554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps].
    Chen YJ; Chai XB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis.
    Ramaswamy US; Melder K; Patel VA; Lee SE
    Otolaryngol Clin North Am; 2021 Aug; 54(4):689-699. PubMed ID: 34215357
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
    Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
    Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
    Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Molecular Therapies in Allergy and Rhinology.
    Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis.
    Licari A; Castagnoli R; De Filippo M; Foiadelli T; Tosca MA; Marseglia GL; Ciprandi G
    Expert Opin Biol Ther; 2020 Jun; 20(6):609-619. PubMed ID: 32053391
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging biologics for the treatment of chronic rhinosinusitis.
    Pauwels B; Jonstam K; Bachert C
    Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine.
    Passali D; Bellussi LM; Damiani V; Tosca MA; Motta G; Ciprandi G
    Acta Biomed; 2020 Feb; 91(1-S):11-18. PubMed ID: 32073556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
    Bachert C; Zhang L; Gevaert P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.
    Latorre M; Bacci E; Seccia V; Bartoli ML; Cardini C; Cianchetti S; Cristofani L; Di Franco A; Miccoli M; Puxeddu I; Celi A; Paggiaro P
    Ther Adv Respir Dis; 2020; 14():1753466620965151. PubMed ID: 33263506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.